{
  "id": "cluster_36_doc1",
  "content": "A research study published in the Journal of Clinical Pharmacy analyzed the effectiveness of biweekly darbepoetin alfa injections for anemia management in patients with stage 3 chronic kidney disease. The study cohort included 127 participants from Coastal Renal Center, with 72% showing improved hemoglobin levels within 12 weeks. Preliminary findings suggest this protocol reduces transfusion requirements by 34% compared to standard care. The study was partially funded through the CKD-ANEM-2022 grant.",
  "metadata": {
    "format": "research_note"
  }
}